Ankerite Pharmaceuticals Private Limited, a active private limited company, was established on 23 January 2006 in Uttar Pradesh, Uttar Pradesh, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24232UP2006PTC031249. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹2.50 M.
It upholds a compliant status. Its leadership includes Kiran Rohatgi (Director), Chandrabhan (Director), Karan Kathuria (Director). Past directors included Kiran Rohatgi, Sunil Rohatgi, Kirti Kumar. It holds ₹0.29 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Md 1\163 Dayakunjmansarover Lucknow, Uttar Pradesh, Uttar Pradesh.
U24232UP2006PTC031249
031249
23 January 2006
₹2.50 M
₹2.50 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Ankerite Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kiran Rohatgi | Director | 30 Sep 2009 | Current |
| Chandrabhan | Director | 11 Jun 2020 | Current |
| Karan Kathuria | Director | 11 Jun 2020 | Current |
| Ishan Arora | Director | 11 Jun 2020 | Current |
| Sunil Rohatgi | Director | 30 Sep 2009 | Current |
| Kirti Kumar | Director | 15 Dec 2008 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 27 Jan 2009 | Past |
| Pramod Abcsdd | Director | 27 Jan 2009 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2009 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2009 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Ankerite Pharmaceuticals Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 88.75% increase in profit. The company's net worth observed a substantial decline by a decrease of 14.73%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Ankerite Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹290,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Feb 2018 | Others | ₹0.29 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Ankerite Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Ankerite Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ankerite Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Ankerite Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Ankerite Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was completed.
Chandrabhan was appointed as a Director was appointed as a Director on 11 Jun 2020 & has been associated with this company since 5 years 5 months . was recorded as a recent event.
The activity Karan Kathuria was appointed as a Director was appointed as a Director on 11 Jun 2020 & has been associated with this company since 5 years 5 months . was completed.
Ishan Arora was appointed as a Director was appointed as a Director on 11 Jun 2020 & has been associated with this company since 5 years 5 months . was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 0.29 M with Charge ID 100171340 was registered on 28 Feb 2018. was documented.
The CIN of Ankerite Pharmaceuticals Private Limited is U24232UP2006PTC031249.
Ankerite Pharmaceuticals Private Limited is headquartered at Md 1\163 Dayakunjmansarover Lucknow, Uttar Pradesh, Uttar Pradesh.
Ankerite Pharmaceuticals Private Limited was incorporated on 23 January 2006.
The current directors of Ankerite Pharmaceuticals Private Limited are
The primary industry of Ankerite Pharmaceuticals Private Limited is Trade.
Ankerite Pharmaceuticals Private Limited is unlisted.
The authorized capital of Ankerite Pharmaceuticals Private Limited is ₹2.50 M, and the paid-up capital is ₹2.50 M.
The compliance status of Ankerite Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX